Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B1 Receptor Antagonists
doi 10.1021/jm061094b.s001
Full Text
Abstract
Available in
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)